Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study

Authors

Bincy Abraham (ORCID: https://orcid.org/0000-0003-0308-1224)
Sunanda V. Kane (ORCID: https://orcid.org/0000-0002-6410-4242)
Uma Mahadevan
Dawn B. Beaulieu
Millie D. Long (ORCID: https://orcid.org/0000-0001-5983-2758)
Xian Zhang (ORCID: https://orcid.org/0000-0003-3572-6971)

Institutions

University of North Carolina at Chapel Hill (US)
Houston Methodist (US)
Mayo Clinic (US)
University of California, San Francisco (US)
Vanderbilt University (US)

Publication Details

Journal: Clinical and Translational Gastroenterology
Published: 2024-11-21
DOI: https://doi.org/10.14309/ctg.0000000000000795
Citations: 4
Primary Topic: Pregnancy and Medication Impact
Type: article
Field-Weighted Citation Impact: 2.17

Funders

Leona M. and Harry B. Helmsley Charitable Trust

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study

Bincy Abraham, Sunanda V. Kane, Uma Mahadevan, Dawn B. Beaulieu et al.

Nov 21, 2024

4 citations

Clinical and Translational Gastroenterology

Pregnancy and Medication Impact

2.17

article

Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study

Bincy Abraham, Sunanda V. Kane, Uma Mahadevan, Dawn B. Beaulieu, Millie D. Long, Xian Zhang

November 21, 2024article en

4 citations

Abstract

No abstract available for this paper.

Clinical and Translational GastroenterologyVol. 15(12)

University of North Carolina at Chapel Hill (US), Houston Methodist (US), Mayo Clinic (US), University of California, San Francisco (US), Vanderbilt University (US)

Leona M. and Harry B. Helmsley Charitable Trust

Good health and well-being

Openalex Percentile: Top 12%

Pregnancy and Medication Impact

2.17

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study — Bincy Abraham, Sunanda V. Kane, et al. · Clinical and Translational Gastroenterology (2024) | TGRS Research Map | TGRS